United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

December 2017 | 107 pages | ID: U26DC942232EN
QYResearch

Abstracts

In this report, the United States Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs in these regions, from 2012 to 2022 (forecast).

United States Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aslan Pharmaceuticals Pte Ltd
• Boehringer Ingelheim GmbH
• GamaMabs Pharma SA
• Hanmi Pharmaceuticals Co Ltd
• Jiangsu Kanion Pharmaceutical Co Ltd
• Minerva Neurosciences Inc
• Pfizer Inc
• Puma Biotechnology Inc
• Shanghai Fosun Pharmaceutical (Group) Co Ltd
• XuanZhu Pharma Co Ltd
• Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Afatinib Dimaleate
• Dacomitinib
• Neratinib
• Neucardin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Cardiovascular
• Central Nervous System
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

1 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS OVERVIEW

1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs by Product Category
  1.2.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Afatinib Dimaleate
  1.2.4 Dacomitinib
  1.2.5 Neratinib
  1.2.6 Neucardin
  1.2.7 Others
1.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
  1.3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Cardiovascular
  1.3.4 Central Nervous System
  1.3.5 Others
1.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
  1.4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
  1.4.5 New England Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
  1.4.6 The South Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
  1.5.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
  2.4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate
  2.4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Price by Region (2012-2017)

4 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2012-2017)
4.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Aslan Pharmaceuticals Pte Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
  6.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GamaMabs Pharma SA
  6.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hanmi Pharmaceuticals Co Ltd
  6.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Jiangsu Kanion Pharmaceutical Co Ltd
  6.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Minerva Neurosciences Inc
  6.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer Inc
  6.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Puma Biotechnology Inc
  6.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
  6.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 XuanZhu Pharma Co Ltd
  6.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Zensun (Shanghai) Sci & Tech Co Ltd

7 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MANUFACTURING COST ANALYSIS

7.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Afatinib Dimaleate Product Picture
Figure Dacomitinib Product Picture
Figure Neratinib Product Picture
Figure Neucardin Product Picture
Figure Others Product Picture
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Central Nervous System Examples
Table Key Downstream Customer in Central Nervous System
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players/Suppliers
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players/Suppliers
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players/Suppliers
Table United States Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share of Top 3 Players/Suppliers
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Receptor Tyrosine Protein Kinase Targeted Drugs Product Category
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Region (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Region (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region in 2016
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Region (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region in 2016
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2016
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2012-2017)
Figure Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type in 2016
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Type (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2016
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Application (2012-2017)
Table Aslan Pharmaceuticals Pte Ltd Basic Information List
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table GamaMabs Pharma SA Basic Information List
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Hanmi Pharmaceuticals Co Ltd Basic Information List
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Jiangsu Kanion Pharmaceutical Co Ltd Basic Information List
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Minerva Neurosciences Inc Basic Information List
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Puma Biotechnology Inc Basic Information List
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Basic Information List
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table XuanZhu Pharma Co Ltd Basic Information List
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in United States (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in United States (2012-2017)
Table Zensun (Shanghai) Sci & Tech Co Ltd Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Table Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Players/Suppliers in 2016
Table Major Buyers of Receptor Tyrosine Protein Kinase Targeted Drugs
Table Distributors/Traders List
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources